Physician profile
Kiran Kumar
NPI 1891744892
$1,452.47
in general payments reported to CMS, 2019-2025
10 companies · $220 in 2025
The $220 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $107 · 2021: $359 · 2022: $187 · 2023: $435 · 2024: $144 · 2025: $220.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $799.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $798.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $377.25 | 2021-2023 | Tecentriq |
| Abbvie INC. | $313.86 | 2021-2023 | |
| Genzyme Corporation | $280.85 | 2023-2024 | |
| Intercept Pharmaceuticals, INC. | $120.65 | 2021 | |
| Phathom Pharmaceuticals, INC. | $110.10 | 2025 | Voquezna |
| Amarin Pharma, INC. | $107.26 | 2019 | |
| Sun Pharmaceutical Industries INC. | $57.71 | 2025 | |
| Viatris Specialty LLC | $51.95 | 2025 | Yupelri |
| Rxsight INC | $19.51 | 2023 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Tempus Ai, INC | $13.33 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kiran Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.